This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Grundy SM, Brewer HB, Jr, Cleeman JI, Smith SC, Jr, Lenfant C, et al. for the American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109:433-8.10.1161/01.CIR.0000111245.75752.C614744958GrundySMBrewerHBJrCleemanJISmithSCJrLenfantCet alfor the American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definitionCirculation2004109433814744958Open DOISearch in Google Scholar
Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999; 16:442-3.10.1046/j.1464-5491.1999.00059.xBalkauBCharlesMAComment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)Diabet Med199916442310342346Open DOISearch in Google Scholar
Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26:3160-7.10.2337/diacare.26.11.3160GenuthSAlbertiKGBennettPBuseJDefronzoRKahnRet alFollow-up report on the diagnosis of diabetes mellitusDiabetes Care2003263160714578255Open DOISearch in Google Scholar
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285: 2486-97.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)JAMA200128524869710.1001/jama.285.19.248611368702Search in Google Scholar
Sirdah MM, Abu Ghali AS, Al Laham NA. The reliability of the National Cholesterol Education Program’s Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians. Diabetes Metab Syndr. 2012; 6:4-8.2301424710.1016/j.dsx.2012.05.017SirdahMMAbuGhali ASAlLaham NAThe reliability of the National Cholesterol Education Program’s Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip PalestiniansDiabetes Metab Syndr201264823014247Search in Google Scholar
Rezaianzadeh A, Namayandeh SM, Sadr SM. National cholesterol education program adult treatment panel III vs international diabetic federation definition of metabolic syndrome, which one is associated with diabetes mellitus and coronary artery disease?. Int J Prev Med. 2012; 3:552-8.RezaianzadehANamayandehSMSadrSMNational cholesterol education program adult treatment panel III vs international diabetic federation definition of metabolic syndrome, which one is associated with diabetes mellitus and coronary artery disease?Int J Prev Med201235528Search in Google Scholar
Eapen D, Kalra GL, Merchant N, Arora A, Khan B V. Metabolic syndrome and cardiovascular disease in South Asians. Vasc Health Risk Manag. 2009; 5: 731-43.19756165EapenDKalraGLMerchantNAroraAKhanB VMetabolic syndrome and cardiovascular disease in South AsiansVasc Health Risk Manag200957314310.2147/VHRM.S5172Search in Google Scholar
Kuge Y, Kume N, Ishino S, Takai N, Ogawa Y, Mukai T, et al. Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits. Biol Pharm Bull. 2008; 31:1475-82.1867007510.1248/bpb.31.1475KugeYKumeNIshinoSTakaiNOgawaYMukaiTet alProminent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbitsBiol Pharm Bull20083114758218670075Search in Google Scholar
Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 1999; 99:3110-7.10.1161/01.CIR.99.24.311010377073KataokaHKumeNMiyamotoSMinamiMMoriwakiHMuraseTet alExpression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesionsCirculation1999993110710377073Open DOISearch in Google Scholar
Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J. 2008; 409: 349-55.10.1042/BJ2007119618092947DunnSVohraRSMurphyJEHomer-VanniasinkamSWalkerJHPonnambalamSThe lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular diseaseBiochem J20084093495518092947Open DOISearch in Google Scholar
Ishino S, Mukai T, Kume N, Asano D, Ogawa M, Kuge Y, et al. Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability—analysis in hypercholesterolemic rabbits. Atherosclerosis. 2007; 195:48-56.1723988710.1016/j.atherosclerosis.2006.11.031IshinoSMukaiTKumeNAsanoDOgawaMKugeYet alLectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability—analysis in hypercholesterolemic rabbitsAtherosclerosis2007195485617239887Search in Google Scholar
Pirillo A, Catapano AL. Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases. Dis Markers. 2013; 35:413-8.2419844210.1155/2013/716325PirilloACatapanoALSoluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseasesDis Markers2013354138380973924198442Search in Google Scholar
Xie Q, Matsunaga S, Niimi S, Ogawa S, Tokuyasu K, Sakakibara Y, et al. Human lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cells. DNA Cell Biol. 2004; 23:111-7.1500075110.1089/104454904322759920XieQMatsunagaSNiimiSOgawaSTokuyasuKSakakibaraYet alHuman lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cellsDNA Cell Biol200423111715000751Search in Google Scholar
Aoyama T, Sawamura T, Furutani Y, Matsuoka R, Yoshida MC, Fujiwara H, et al. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J. 1999; 339:177-84.10.1042/bj339017710085242AoyamaTSawamuraTFurutaniYMatsuokaRYoshidaMCFujiwaraHet alStructure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) geneBiochem J199933917784Open DOISearch in Google Scholar
Navarra T, Del Turco S, Berti S, Basta G. The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. J Atheroscler Thromb. 2010; 17:317-31.10.5551/jat.322820009416NavarraTDelTurco SBertiSBastaGThe lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implicationsJ Atheroscler Thromb2010173173120009416Open DOISearch in Google Scholar
Murase T, Kume N, Kataoka H, Minami M, Sawamura T, Masaki T, et al. Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler Thromb Vasc Biol. 2000; 20:715-20.1071239610.1161/01.ATV.20.3.715MuraseTKumeNKataokaHMinamiMSawamuraTMasakiTet alIdentification of soluble forms of lectin-like oxidized LDL receptor-1Arterioscler Thromb Vasc Biol20002071520Search in Google Scholar
Brinkley TE, Kume N, Mitsuoka H, Brown MD, Phares DA, Ferrell RE, et al. Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels. Exp Physiol. 2008; 93:1085-90.1846906610.1113/expphysiol.2008.042267BrinkleyTEKumeNMitsuokaHBrownMDPharesDAFerrellREet alVariation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levelsExp Physiol200893108590265212918469066Search in Google Scholar
Brinkley TE, Kume N, Mitsuoka H, Phares DA, Hagberg JM. Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women. Obesity (Silver Spring). 2008; 16:1454-6.10.1038/oby.2008.21318388896BrinkleyTEKumeNMitsuokaHPharesDAHagbergJMElevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal womenObesity (Silver Spring)20081614546267780118388896Open DOISearch in Google Scholar
Tan KC, Shiu SW, Wong Y, Leng L, Bucala R. Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus. J Lipid Res. 2008; 49: 1438-44.10.1194/jlr.M700551-JLR20018408244TanKCShiuSWWongYLengLBucalaRSoluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitusJ Lipid Res20084914384418408244Open DOISearch in Google Scholar
Pongchaiyakul C, Nguyen TV, Kosulwat V, Rojroongwasinkul N, Charoenkiatkul S, Pongchaiyakul C, et al. Defining obesity by body mass index in the Thai population: an epidemiologic study. Asia Pac J Clin Nutr. 2006; 15:293-9.16837420PongchaiyakulCNguyenTVKosulwatVRojroongwasinkulNCharoenkiatkulSPongchaiyakulCet alDefining obesity by body mass index in the Thai population: an epidemiologic studyAsia Pac J Clin Nutr2006152939Search in Google Scholar
Pongchaiyakul C, Nguyen T V, Wanothayaroj E, Karusan N, Klungboonkrong V. Prevalence of metabolic syndrome and its relationship to weight in the Thai population. J Med Assoc Thai. 2007; 90: 459-67.17427521PongchaiyakulCNguyenT VWanothayarojEKarusanNKlungboonkrongVPrevalence of metabolic syndrome and its relationship to weight in the Thai populationJ Med Assoc Thai20079045967Search in Google Scholar
Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007; 92:399-404.10.1210/jc.2006-051317284640GrundySMMetabolic syndrome: a multiplex cardiovascular risk factorJ Clin Endocrinol Metab20079239940417284640Open DOISearch in Google Scholar
Kobayashi N, Takano M, Hata N, Kume N, Yamamoto M, Yokoyama S, et al. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography. Int J Cardiol. 2013; 168:3217-23.10.1016/j.ijcard.2013.04.11023632121KobayashiNTakanoMHataNKumeNYamamotoMYokoyamaSet alSoluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomographyInt J Cardiol201316832172323632121Open DOISearch in Google Scholar
Nomata Y, Kume N, Sasai H, Katayama Y, Nakata Y, Okura T, et al. Weight reduction can decrease circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in overweight middle-aged men. Metabolism. 2009; 58:1209-14.1959205510.1016/j.metabol.2009.06.018NomataYKumeNSasaiHKatayamaYNakataYOkuraTet alWeight reduction can decrease circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in overweight middle-aged menMetabolism20095812091419592055Search in Google Scholar
Hayashida K, Kume N, Murase T, Minami M, Nakagawa D, Inada T, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation. 2005; 112:812-8.10.1161/CIRCULATIONAHA.104.46839716061745HayashidaKKumeNMuraseTMinamiMNakagawaDInadaTet alSerum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosisCirculation2005112812816061745Open DOISearch in Google Scholar
Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kominami G, Kita T. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome—Comparison with other biomarkers. J Cardiol. 2010; 56:159-65.2060569910.1016/j.jjcc.2010.05.002KumeNMitsuokaHHayashidaKTanakaMKominamiGKitaTSoluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome—Comparison with other biomarkersJ Cardiol2010561596520605699Search in Google Scholar
Civelek S, Kutnu M, Uzun H, Erdenen F, Altunoglu E, Andican G, et al. Soluble lectin-like oxidized LDL receptor 1 as a possible mediator of endothelial dysfunction in patients with metabolic syndrome. J Clin Lab Anal. 2015; 29:184-90.10.1002/jcla.2174824798146CivelekSKutnuMUzunHErdenenFAltunogluEAndicanGet alSoluble lectin-like oxidized LDL receptor 1 as a possible mediator of endothelial dysfunction in patients with metabolic syndromeJ Clin Lab Anal20152918490680672924798146Open DOISearch in Google Scholar
Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007; 7:220.1772769710.1186/1471-2458-7-220HildrumBMykletunAHoleTMidthjellKDahlAAAge-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 studyBMC Public Health20077220204894717727697Search in Google Scholar
Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kita T. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome-a pilot study. Circ J. 2010; 74:1399-404.2046715410.1253/circj.CJ-09-0924KumeNMitsuokaHHayashidaKTanakaMKitaTSoluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome-a pilot studyCirc J201074139940420467154Search in Google Scholar
